In 2025, the growth rate of nasal and throat rinsing product sales on marketplaces is five times higher than in offline retail
31.10.2025
RetailDrug groupE-com

According to the RNC Pharma® database “Audit of Retail Sales of Medicinal Products in Russia (total sell-out)”, in Q1–Q3 2025, Russian consumers purchased 22.7 million packages of nasal and throat rinsing products based on saline solutions, including sea water1, spending a total of RUB 10.8 billion (in retail prices including VAT). Compared with the same period in 2024, sales in this category grew by 10.8% in value and 4.3% in volume. In 2024 vs. 2023, value growth was significantly higher (+17%), while volume growth was comparable (+4.2%).

The role of online sales in this category continues to expand: in Q1–Q3 2025, value dynamics in the e-commerce channel exceeded +46%, which is five times higher than the growth rate in traditional retail outlets. The total value share of marketplaces reached 5%, compared to 3.8% a year earlier. The largest online platforms — Ozon and Yandex Market — accounted for a combined 61% of e-commerce turnover in this category. By contrast, the FMCG channel’s share declined and currently does not exceed 0.2%.

During the reporting period, 36 companies were active in the retail market, offering 40 brands and a combined 223 SKUs. Remarkably, the top 10 brands accounted for 95.7% of total value sales.

The largest consumer spending was directed toward Aqualor (Nizhpharm), which held a 37.7% market share in value terms. Aqua Maris (Jadran Galenski Laboratorij, Croatia) retained the second position with 28.2%, while LinAqua (Groteks, Russia) ranked third, generating 11.7% of total sales. The Dolphin device and nasal rinsing solution (Zentiva) ranked fourth, showing +19% growth in value and +4% in volume versus Q1–Q3 2024.

Among the top-performing products, Rankof (Profit Pharm) demonstrated the highest growth — sales nearly tripled in value and rose 2.3 times in volume. Other notable gainers included Nosifit (Artelar, +167%) and Aquarosa (KS Trade, +103%).

For the second consecutive year, demand for LinAqua (Groteks) continued to decline — sales fell by 26% in value and 35% in volume year-on-year. The drop affected the entire product line (around 16 SKUs), likely due to contract manufacturing of several SKUs under other private labels such as Akvazivin and Nosifit, which are also produced by the company. Within the Top 10, Aquanazal (Altayvitamins) also recorded a decline of –12% in value and –24% in volume.

Outside the top 10, one of the strongest performers was Aspecton nasal spray (Krevel), whose sales increased 12-fold in value and 16-fold in volume year-on-year.

Top 10 Brands of nasal and throat rinsing products based on saline solutions including sea water by retail sales value in Russia, including marketplaces and FMCG channel, Q1–Q3 2025

Brand Company Share in Q1-Q3 2025, %, RUB  Dynamics vs. Q1–Q3 2024, %, RUB
1 Aqualor Nizhpharm 37.7 14
2 Aqua Maris Jadran Galenski Laboratorij 28.2 13
3 LinAqua Groteks 11.7 -26
4 Dolphin Zentiva 9.3 19
5 Nosifit Artelar 2.3 167
6 Aquarosa KS Trade 1.5 103
7 Akvazivin Erkapharm 1.5 13
8 Aquanazal Altayvitamins 1.4 -12
9 Rankof Profit Pharm 1.2 188
10 Quixx Menarini 0.8 10
Source: RNC Pharma®, Audit of Retail Sales of Medicinal Products in Russia (total sell-out)

[1] The analysis covered all products in the form of aerosols, sprays, drops, lyophilizates, and powders for solution preparation containing sea water and sodium chloride, as well as specialized devices designed for nasal and throat rinsing and irrigation, registered as medicinal products, medical devices, or cosmetic products.

Leave your contact details and we will contact you

Close
Subscribe to our newsletter to always be up to date with the latest news
Select topics
All
Pharmaceuticals
Veterinary
Parapharmaceuticals
FMCG
I agree to the processing of personal data in accordance with the Personal Data Processing Policy and want to receive information materials